Patrick W Heiser

No ORCID on file · 3 papers in corpus · active 2024-2026

Study types

  • article 1
  • rct 1

Condition tags

  • endometriosis 2
  • endometrioma 2
  • die_deep_infiltrating 2
  • adenomyosis 2
  • chronic_pelvic_pain 1
  • infertility 1
2026
Safety evaluation of a novel progesterone vaginal ring (PVR) for luteal phase support: SARA trial
Drug delivery and translational research ·doi:10.1007/s13346-026-02158-x

After manufacturing changes, the safety and tolerability of the progesterone vaginal ring (PVR) was compared to findings from the similarly designed phase 3 trial. This prospective, open-label, single-arm, multi-center U.S. trial was conduc…

rct 2025
Quinagolide vaginal ring for reduction of endometriotic lesions: Results from the QLARITY trial
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2025.113946

BACKGROUND: This study evaluated the effectiveness of quinagolide vaginal ring on reducing total lesion size in endometrioma, deep infiltrating endometriosis (DIE), and adenomyosis, as assessed using high-resolution MRI and imaging biomarke…

article 2024
O-021 Magnetic Resonance Imaging (MRI) evaluation of Quinagolide Vaginal Ring (QVR) treatment on endometrioma, Deep Infiltrating Endometriosis (DIE), and adenomyosis lesion characteristics: QLARITY trial results
·doi:10.1093/humrep/deae108.021

Abstract Study question Can MRI provide a useful assessment of changes to endometrioma, DIE, and adenomyosis lesion burden resulting from QVR treatment? Summary answer MRI successfully measured changes in the number, size, diffusion, and pe…